BCYC Bicycle Therapeutics
- 21.745
- -0.435-1.96%
Bicycle Therapeutics News
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading
European equities traded in the US as American depositary receipts were trending modestly higher late Friday morning, rising 0.29% to 1,426.43 on the S&P Europe Select ADR Index. The index is set to c
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
European equities traded in the US as American depositary receipts started the week off on a positive note, rising 0.42% to 1,380.39 on the S&P Europe Select ADR Index. From continental Europe, the ga
Bicycle Therapeutics First Quarter 2024 Earnings: Beats Expectations
Express News | HC Wainwright & Co. Reiterates Buy on Bicycle Therapeutics, Maintains $55 Price Target
Bicycle Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 122.94% HC Wainwright & Co. → $55 Reiterates Buy → Buy 04/10/2024 74.3% Needham → $43 Reiterate
Barclays Sticks to Its Buy Rating for Bicycle Therapeutics (BCYC)
Bicycle Therapeutics: Strong Q1 Performance and Promising Clinical Trials Drive Buy Rating
Power Pedal: How Insider Voting Clout Could Sway Bicycle Therapeutics' Future
Analysts' Top Healthcare Picks: Lantheus (LNTH), Bicycle Therapeutics (BCYC)
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.25% to 1,364.91 on the S&P Europe Select ADR Index. From continental Europe,
Express News | Bicycle Therapeutics' Cash And Cash Equivalents Of $457M As Of March 31, 2024, Expected To Provide Financial Runway Into 2026
Express News | Bicycle Therapeutics Q1 Basic EPS USD -0.62
Express News | Bicycle Therapeutics Q1 Pretax Profit USD -26.913 Million
Express News | Bicycle Therapeutics Q1 Operating Incom USD -31.716 Million
Express News | Bicycle Therapeutics Q1 Net Income USD -26.563 Million
Bicycle Therapeutics 1Q Loss $26.6M >BCYC
Bicycle Therapeutics 1Q Loss $26.6M >BCYC
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.5% to 1,380.32 on the S&P Europe Select ADR Index. With the gain, the index is set to c
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
Bicycle Therapeutics plc (NASDAQ:BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced the
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading
After closing out last week more than 2% lower, European equities traded in the US as American depositary receipts rebounded Monday morning, rising 1.09% to 1,340.58 on the S&P Europe Select ADR Index
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains
Analysis
Price Target
No Data
